Patient characteristics
| Dose, mg/kg per day . | 30 . | 60 . | 80 . | 100-120 . | Overall . |
|---|---|---|---|---|---|
| n | 3 | 20 | 3 | 7 | 33 |
| Male/female | 0/3 | 11/9 | 2/1 | 4/3 | 17/16 |
| Age, mean (SD), y | 67.7 (6.0) | 67.5 (11.1) | 66.3 (6.5) | 62.6 (9.3) | 66.3 (9.9) |
| LDH elevated, n (%) | 2 | 7 | 2 | 3 | 14 (42) |
| WHO, n (%) | |||||
| 0 | 2 | 13 | 2 | 5 | 22 (71) |
| 1 | 1 | 4 | 1 | 2 | 8 (26) |
| 2 | 0 | 1 | 0 | 0 | 1 (3) |
| Ann Arbor, n | |||||
| 2 | 0 | 7 | 2 | 2 | 11 (44) |
| 3 | 1 | 2 | 1 | 0 | 4 (16) |
| 4 | 1 | 6 | 0 | 3 | 10 (40) |
| No ex nodal manifest, n (%) | |||||
| 0 | 1 | 14 | 3 | 3 | 21 (64) |
| 1 | 1 | 4 | 0 | 4 | 9 (27) |
| 2 | 1 | 1 | 0 | 0 | 2 (6) |
| 3 | 0 | 1 | 0 | 0 | 1 (3) |
| IPI, n (%) | |||||
| 0 | 0 | 2 | 0 | 1 | 3 (11) |
| 1 | 0 | 3 | 2 | 2 | 7 (26) |
| 2 | 2 | 4 | 0 | 4 | 10 (37) |
| 3 | 0 | 3 | 1 | 0 | 4 (15) |
| 4 | 1 | 2 | 0 | 0 | 3 (11) |
| B-symptoms, n (%) | 0 | 2 | 1 | 0 | 3 (13) |
| Bulky disease, n (%) | 0 | 1 | 0 | 0 | 1 (5) |
| Dose, mg/kg per day . | 30 . | 60 . | 80 . | 100-120 . | Overall . |
|---|---|---|---|---|---|
| n | 3 | 20 | 3 | 7 | 33 |
| Male/female | 0/3 | 11/9 | 2/1 | 4/3 | 17/16 |
| Age, mean (SD), y | 67.7 (6.0) | 67.5 (11.1) | 66.3 (6.5) | 62.6 (9.3) | 66.3 (9.9) |
| LDH elevated, n (%) | 2 | 7 | 2 | 3 | 14 (42) |
| WHO, n (%) | |||||
| 0 | 2 | 13 | 2 | 5 | 22 (71) |
| 1 | 1 | 4 | 1 | 2 | 8 (26) |
| 2 | 0 | 1 | 0 | 0 | 1 (3) |
| Ann Arbor, n | |||||
| 2 | 0 | 7 | 2 | 2 | 11 (44) |
| 3 | 1 | 2 | 1 | 0 | 4 (16) |
| 4 | 1 | 6 | 0 | 3 | 10 (40) |
| No ex nodal manifest, n (%) | |||||
| 0 | 1 | 14 | 3 | 3 | 21 (64) |
| 1 | 1 | 4 | 0 | 4 | 9 (27) |
| 2 | 1 | 1 | 0 | 0 | 2 (6) |
| 3 | 0 | 1 | 0 | 0 | 1 (3) |
| IPI, n (%) | |||||
| 0 | 0 | 2 | 0 | 1 | 3 (11) |
| 1 | 0 | 3 | 2 | 2 | 7 (26) |
| 2 | 2 | 4 | 0 | 4 | 10 (37) |
| 3 | 0 | 3 | 1 | 0 | 4 (15) |
| 4 | 1 | 2 | 0 | 0 | 3 (11) |
| B-symptoms, n (%) | 0 | 2 | 1 | 0 | 3 (13) |
| Bulky disease, n (%) | 0 | 1 | 0 | 0 | 1 (5) |
SD, standard deviation.